Optimal front line treatment for European patients harboring EGFR mutations: Do longitude and race make a difference?

by Landi, Lorenza, Cappuzzo, Federico
Published 2012

Writing in PROSE proteomic-based selection for second line treatment in non-small-cell lung cancer

by Landi, Lorenza, Cappuzzo, Federico
Published in Ann Transl Med (2015)

EGFR TKIs as maintenance therapy in NSCLC: Finding the old in the new INFORMation

by Landi, Lorenza, Cappuzzo, Federico
Published in Transl Lung Cancer Res (2012)

Targeting MET in NSCLC: looking for a needle in a haystack

by Landi, Lorenza, Cappuzzo, Federico
Published in Transl Lung Cancer Res (2014)

Irreversible EGFR-TKIs: dreaming perfection

by Landi, Lorenza, Cappuzzo, Federico
Published in Transl Lung Cancer Res (2013)

MET deregulation in breast cancer

by Minuti, Gabriele, Landi, Lorenza
Published in Ann Transl Med (2015)

Achievements and future developments of ALK-TKIs in the management of CNS metastases from ALK-positive NSCLC

by Landi, Lorenza, Cappuzzo, Federico
Published in Transl Lung Cancer Res (2016)

A few pills twice a day keep ALK-positive non-small-cell lung cancer at bay

by Landi, Lorenza, Cappuzzo, Federico
Published in J Thorac Dis (2017)

Cetuximab in the treatment of advanced non-small cell lung cancer: FISHing for a miraculous catch

by Landi, Lorenza, Rossi, Antonio
Published in J Thorac Dis (2018)

How selecting best upfront therapy for metastatic disease?—Focus on ROS1-rearranged disease

by Landi, Lorenza, Cappuzzo, Federico
Published in Transl Lung Cancer Res (2020)

Overcoming resistance to first/second generation epidermal growth factor receptor tyrosine kinase inhibitors and ALK inhibitors in oncogene-addicted advanced non-small cell lung ca...

by Romanidou, Ourania, Landi, Lorenza, Cappuzzo, Federico, Califano, Raffaele
Published in Ther Adv Med Oncol (2016)

MET overexpression and gene amplification in NSCLC: a clinical perspective

by Landi, Lorenza, Minuti, Gabriele, D’Incecco, Armida, Salvini, Jessica, Cappuzzo, Federico
Published in Lung Cancer (Auckl) (2013)

COVID‐19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience

by Barba, Maddalena, Krasniqi, Eriseld, Pizzuti, Laura, Mazzotta, Marco, Marinelli, Daniele, Giuliano, Greta, Di Liso, Francesca Sofia, Cappuzzo, Federico, Landi, Lorenza, Tomao, Silverio, Ciliberto, Gennaro, Vici, Patrizia
Published in Breast J (2021)

Cancer Stem Cells Sensitivity Assay (STELLA) in Patients with Advanced Lung and Colorectal Cancer: A Feasibility Study

by D’Arcangelo, Manolo, Todaro, Matilde, Salvini, Jessica, Benfante, Antonina, Colorito, Maria Luisa, D’Incecco, Armida, Landi, Lorenza, Apuzzo, Tiziana, Rossi, Elisa, Sani, Spartaco, Stassi, Giorgio, Cappuzzo, Federico
Published in PLoS One (2015)

The neuropilin 2 isoform NRP2b uniquely supports TGFβ-mediated progression in lung cancer

by Gemmill, Robert M., Nasarre, Patrick, Nair-Menon, Joyce, Cappuzzo, Federico, Landi, Lorenza, D’Incecco, Armida, Uramoto, Hidetaka, Yoshida, Takeshi, Haura, Eric B., Armeson, Kent, Drabkin, Harry A.
Published in Sci Signal (2017)

microRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers

by Gasparini, Pierluigi, Cascione, Luciano, Landi, Lorenza, Carasi, Stefania, Lovat, Francesca, Tibaldi, Carmelo, Alì, Greta, D’Incecco, Armida, Minuti, Gabriele, Chella, Antonio, Fontanini, Gabriella, Fassan, Matteo, Cappuzzo, Federico, Croce, Carlo M.
Published in Proc Natl Acad Sci U S A (2015)

The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer

by Bronte, Giuseppe, Puccetti, Maurizio, Petracci, Elisabetta, Landi, Lorenza, Cravero, Paola, Scodes, Simona, Ulivi, Paola, Ravaioli, Sara, Tumedei, Maria Maddalena, Burgio, Marco Angelo, Cappuzzo, Federico, Delmonte, Angelo, Crinò, Lucio, Bravaccini, Sara
Published in Front Oncol (2021)

Circulating programmed death ligand-1 (cPD-L1) in non-small-cell lung cancer (NSCLC)

by Vecchiarelli, Silvia, Passiglia, Francesco, D’Incecco, Armida, Gallo, Marianna, De Luca, Antonella, Rossi, Elisa, D’Incà, Federica, Minuti, Gabriele, Landi, Lorenza, Bennati, Chiara, Spreafico, Michela, D’Arcangelo, Manolo, Mazza, Valentina, Normanno, Nicola, Cappuzzo, Federico
Published in Oncotarget (2018)

Concomitant TP53 Mutation Confers Worse Prognosis in EGFR-Mutated Non-Small Cell Lung Cancer Patients Treated with TKIs

by Canale, Matteo, Petracci, Elisabetta, Delmonte, Angelo, Bronte, Giuseppe, Chiadini, Elisa, Ludovini, Vienna, Dubini, Alessandra, Papi, Maximilian, Baglivo, Sara, De Luigi, Nicoletta, Verlicchi, Alberto, Chiari, Rita, Landi, Lorenza, Metro, Giulio, Burgio, Marco Angelo, Crinò, Lucio, Ulivi, Paola
Published in J Clin Med (2020)

Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer

by D’Arcangelo, Manolo, D’Incecco, Armida, Ligorio, Claudia, Damiani, Stefania, Puccetti, Maurizio, Bravaccini, Sara, Terracciano, Luigi, Bennati, Chiara, Minuti, Gabriele, Vecchiarelli, Silvia, Landi, Lorenza, Milesi, Marina, Meroni, Alberto, Ravaioli, Sara, Tumedei, Maria Maddalena, Incarbone, Matteo, Cappuzzo, Federico
Published in Oncotarget (2019)